Amarantus BioScience (Seller)Avant Diagnostics (Buyer)
Avant acquiring the Amarantus Diagnostics subsidiary of Amarantus BioScience in a stock deal that values the subsidiary at $25.6 million.
Memory Dx (Licensor)Amarantus BioScience (Licensee)
Memory Dx granted Amarantus an exclusive option to license Memory Dx's LymPro Test to aid in the diagnosis of Alzheimer's disease
Set Email Alert